Table 1.

Baseline and transplant characteristics of patients with Alport syndrome compared to patients with end-stage kidney disease (ESKD) from other causes.

Variables	Non-Alport renal disease N = 3856	Alport syndrome N = 62	p values
Age at transplant, mean (sd)	41.9 (16.3)	33.31 (12.65)	<0.001
Age at ESKD, mean (sd)	39.7 (16.0)	30.7 (12.3)	<0.001
Sex, % male/female	63.6/36.4	83.9/16.1	0.001
Time on transplant waiting pool in months, median (IQR)	13.1 (6.2–24.6)	12.9 (4.4–22.4)	0.515
Cold ischemic time in hours, median (IQR)	19 (16–22)	20 (17–23)	0.232
HLA mismatches, median (IQR)	3 (2–4)	3 (2–4)	0.372
Transplant number, % first transplants	86.0	80.6	0.232
Living donor transplants, %	7.4	14.5	0.034
Pre-emptive transplants, %	6.0	1.6	0.146
PRA groups,% 0–10, 11–49, 50–100	62.8/18.0/19.2	76.7/6.7/16.7	0.045